Document is current
Any future updates will be listed below
-
Authors
Shapira, Guy https://orcid.org/0000-0001-9376-4955
Karmon, Gidon
Hacohen-Kleiman, Gal
Ganaiem, Maram
Shazman, Shula
Theotokis, Paschalis https://orcid.org/0000-0001-8607-6695
Grigoriadis, Nikolaos
Shomron, Noam
Gozes, Illana https://orcid.org/0000-0001-9796-2430
- License Information
-
More Information
Article History
Received: 30 July 2024
Revised: 20 November 2024
Accepted: 18 December 2024
First Online: 23 December 2024
Competing interests
: The use of davunetide is under patent protection. Professor Illana Gozes serves as Vice President Drug Development, Exonavis Therapeutics Ltd.
: Animal procedures were approved by the institutional animal care and use committee of Tel Aviv University and the Israeli Ministry of Health. All methods were performed in accordance with the relevant guidelines and regulations. No human studies were performed (not applicable).
